254
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Bovine Spongiform Encephalopathy A Review

&
Pages 57-63 | Received 31 Dec 1991, Accepted 12 Mar 1992, Published online: 11 Nov 2011
 

Abstract

Bovine spongiform encephalopathy (BSE) or ‘mad cow disease’ is a new disease with an elusive transmissible agent. However, a ‘Prion protein’ (PrP) of about 27K Dalton has been observed to play an essential role in the pathogenecity of BSE. Friesian cattle of 3–6 years of age have been found susceptible. Common symptoms include weight loss, unmanageable behaviour, traumatic damage due to locomotor deficits and prolonged recumbency. Recent studies suggest that amino acid substitutions in PrP may modulate the development of prion diseases. Histopathology of brain stem grey matter showed moderate number of discrete ovoid and spherical vacuoles in the neuropil causing spongiform change. The electron microscopic detection of abnormal fibrils called scrapie-associated fibrils' in the extracts of affected brain may be used as an additional diagnostic ceiterion. Transmission has been suspected due to feeding of offals meal, meat meal and bone meal of diseased animals Susceptibility of BSE is probably inherited. However, extensive investigations are required for the establishment of aetiology, transmission, pathogenicity and zoonotic potential of BSE, a new nervous disorder of bovines.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.